Tools

LEADER 03445cam 2200637 i 4500

001 on1379293534;

003 OCoLC;

005 20231106090727.0;

006 m o d f ;

007 cr |||||||||||;

008 230518s2023 dcu ob f000 0 eng c;

024 8 a| 51-718q| (GPO jacket number ; pt. 1);

024 8 a| 52-165q| (GPO jacket number ; pt. 2);

035 a| (Sirsi) o1379293534;

042 a| pcc;

043 a| n-us---;

049 a| ERE#;

074 a| 1016-C (online);

086 0 a| Y 4.OV 2:118-31;

086 0 a| Y 4.OV 2:118-13;

088 a| Serial no. 118-31 (United States. Congress. House. Committee on Oversight and Accountability);

088 a| Serial no. 118-13 (United States. Congress. House. Committee on Oversight and Accountability);

245 10 a| FDA oversight :b| hearing before the Subcommittee on Health Care and Financial Services of the Committee on Oversight and Accountability, House of Representatives, One Hundred Eighteenth Congress, first session.;

246 3 a| Food and Drug Administration oversight;

264 1 a| Washington :b| U.S. Government Publishing Office,c| 2023.;

300 a| 1 online resource (volumes);

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

505 0 a| Pt. 1. Infant formula shortage -- Pt. 2. Responsibility for the infant formula shortage.;

500 a| "March 28, 2023"--Pt. 1.;

500 a| "May 11, 2023"--Pt. 2.;

500 a| In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).;

500 a| "Serial no. 118-13"--Pt. 1.;

500 a| "Serial no. 118-31"--Pt. 2.;

500 a| GPO Cataloging Record Distribution Program (CRDP).;

504 a| Includes bibliographical references.;

511 0 a| "Hearing witnesses: Mr. Frank Yiannas, M.P.H., Former Deputy Commissioner, Office of Food Policy & Response, U.S. Food & Drug Administration; Dr. Peter Lurie, M.D., M.P.H. (Minority Witness), President & Executive Director, Center for Science in the Public Interest"--Pt. 1.;

511 0 a| "5110 Hearing witnesses: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration"--Pt. 2.;

518 a| "Date of hearing: 2023-03-28"--Pt. 1.;

518 a| "Date of hearing: 2023-05-11"--Pt. 2.;

588 a| Description based on online resource; title from PDF title page, pt. 1 (GovInfo, viewed May 18, 2023).;

650 0 a| Infant formulasz| United States.=| ^A139968;

650 0 a| Business logisticsz| United States.=| ^A115723;

610 10 a| United States.b| Food and Drug Administration.=| ^A1253;

650 7 a| Congress.2| cgpa;

650 7 a| Government Operations and Politics.2| cgpa;

655 7 a| Legislative hearings.2| lcgft;

776 08 i| Print version:a| United States. Congress. House. Committee on Oversight and Accountability.t| FDA oversightw| (OCoLC)1379292379;

856 40 u| https://purl.fdlp.gov/GPO/gpo212601;

949 a| Click on web addressw| asish| joyner94;

596 a| 1;

998 a| 6157464;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 6157464-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 6/20/2023x| EDOCUMENTz| JERESOURCE;

FDA oversight : hearing before the Subcommittee on Health Care and Financial Services of the Committee on Oversight and Accountability, House of Representatives, One Hundred Eighteenth Congress, first session.

Author/creator	United States
Format	Electronic
Publication	Washington : U.S. Government Publishing Office, 2023.
Description	1 online resource (volumes)
Supplemental Content	https://purl.fdlp.gov/GPO/gpo212601
Subjects	United States. Food and Drug Administration. Infant formulas--United States. Business logistics--United States.

Variant title	Food and Drug Administration oversight
Contents	Pt. 1. Infant formula shortage -- Pt. 2. Responsibility for the infant formula shortage.
General note	"March 28, 2023"--Pt. 1.
General note	"May 11, 2023"--Pt. 2.
General note	In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).
General note	"Serial no. 118-13"--Pt. 1.
General note	"Serial no. 118-31"--Pt. 2.
General note	GPO Cataloging Record Distribution Program (CRDP).
Bibliography note	Includes bibliographical references.
Performer	"Hearing witnesses: Mr. Frank Yiannas, M.P.H., Former Deputy Commissioner, Office of Food Policy & Response, U.S. Food & Drug Administration; Dr. Peter Lurie, M.D., M.P.H. (Minority Witness), President & Executive Director, Center for Science in the Public Interest"--Pt. 1.
Performer	"5110 Hearing witnesses: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration"--Pt. 2.
Date/time/place of a event note	"Date of hearing: 2023-03-28"--Pt. 1.
Date/time/place of a event note	"Date of hearing: 2023-05-11"--Pt. 2.
Source of description	Description based on online resource; title from PDF title page, pt. 1 (GovInfo, viewed May 18, 2023).
Issued in other form	Print version: United States. Congress. House. Committee on Oversight and Accountability. FDA oversight
Genre/form	Legislative hearings.
Standard identifier#	51-718 (GPO jacket number ; pt. 1)
Standard identifier#	52-165 (GPO jacket number ; pt. 2)
Technical rpt number	Serial no. 118-31 (United States. Congress. House. Committee on Oversight and Accountability)
Technical rpt number	Serial no. 118-13 (United States. Congress. House. Committee on Oversight and Accountability)
GPO item number	1016-C (online)
Govt. docs number	Y 4.OV 2:118-31
Govt. docs number	Y 4.OV 2:118-13

FDA oversight : hearing before the Subcommittee on Health Care and Financial Services of the Committee on Oversight and Accountability, House of Representatives, One Hundred Eighteenth Congress, first session.

Click here for more information about this title